Active Implantable Device

Global Active Implantable Device Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 507 | Number of pages: 202 | Publish Date: Jul 2019 | Category: ICT and Media
Active Implantable Device Market is valued at USD 23361.0 Million in 2018 and expected to reach USD 39170.8 Million by 2025 with the CAGR of 7.66 % over the forecast period. Increasing prevalence of chronic diseases such as cardiovascular, neurological diseases etc. is the key factor driving the market growth.

Scope of Active Implantable Device Market Report:

Active implantable devices are medical devices like cochlear implants, implantable defibrillators, implantable cardiac monitoring devices, implantable nerve stimulators, ventricular assist devices (VAD) which are intended to be totally or partially introduce surgically into the human body or by some medical intervention into natural orifice, and which are also intended to remain after the procedure. Primarily they are used to detect, monitor, avert, alleviate or treat disease or conditions in the patients. The large number of factors are boosting the global consumption of medical implantable devices. Some of them are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases and the rising intake of junk food is leading to the increased incidences of dental issues. In future, these factors are expected to arise as the high-impact drivers of the global active implantable medical devices. Global active implantable medical devices market report is segmented on the basis of product, application, end-user and region & country level. Based upon product, active implantable medical devices market is classified into orthopedic implants, dental implants, breast cancer, cardiovascular implants, intraocular lens and others. Based upon application, active implantable medical devices market is classified into cardiovascular, neurological, hearing impartment and others. Based upon end-user, active implantable medical devices market is classified into hospitals, specialty clinics and ambulatory surgical center. The regions covered in this active implantable medical devices market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Active implantable medical devices is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Active Implantable Device Market Report- Some major key players for global active implantable device market Nrotron Biotechnology Co Ltd, Abbott Laboratories, BIOTRONIK SE &Co. KG, William Demart Holding A/S, LivaNova PLC, Sonova Holding AG, Cochlear Limited, Boston Scientific Corporation, MED-EL and Medtronic plc. and others. The Increasing Need for Faster, Effective, and Safer Devices and Technological Advancements in Cardiac Implant are the Major Factors Driving the Market Growth. Nowadays, large number of chronic disease are increasing among the population which results in increased demand for faster, effective, and safer implanting devices. In addition, increasing healthcare expenditure, growing elderly population, rising governments funding for R&D activates and technological advancement are some of major factors of driving the market growth. Furthermore, favorable reimbursement policies, rising accessibility for healthcare facilities, rapid development of the healthcare sector, changing lifestyle and increasing awareness regarding cardiac diseases, are some other factors expected to foster growth revenue of the target market over the forecasted period. However, high price of implants and an unfavorable repayment scenario are the major obstacle for the market growth. Moreover, increasing research and development in implanting device market and the high preference of minimally invasive procedures can provide lucrative opportunities for the growth of the market. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Active Implantable Device Market. Key Benefits for Active Implantable Device Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Active Implantable Device Market Segmentation:

By Product: • Orthopedic implants o Spinal Implants o Reconstructive Joint Replacement • Dental Implants • Breast Cancer • Cardiovascular Implants • Intraocular lens • Other Implants By Application: • Cardiovascular • Neurological • Hearing impartment • Others By End Users: • Hospitals • Specialty Clinics • Ambulatory Surgical Center North America is Expected to Dominate the Global Active Implanting Device Market North America holds a major share of the global active implantable devices market. Largest share of North America is primarily attributed to the growth in geriatric population, increasing prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, rising development of innovative and technologically advanced products and increasing healthcare expenditure in this region. However, Asia-Pacific is commanded to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the growth in geriatric population, growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development and growing demand for advanced technologies of develop advanced products. By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa Active Implantable Device Market Key Players: • Nrotron Biotechnology Co Ltd • Abbott Laboratories • BIOTRONIK SE &Co. KG • William Demart Holding A/S • LivaNova PLC • Sonova Holding AG • Cochlear Limited • Boston Scientific Corporation • MED-EL and Medtronic plc. • Others. This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Antimony Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Antimony Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Antimony Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Antimony Market Overview: Quantitative Analysis
3.1. Global Antimony Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Antimony Market Revenue Market Share (%), 2014- 2025
3.3. Global Antimony Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Antimony Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Antimony Market Analysis: By Product Type
5. Chapter – Global Antimony Market Analysis: By End User  
6. Chapter – Global Antimony Market Analysis: By Application
7. Chapter - Global Antimony Market Analysis: By Manufacture
7.1. Global Antimony Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Antimony Market Share (%), by Manufacturer, 2018
7.3. Global Antimony Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Antimony Market Share (%), by Manufacturer, 2018
7.5. Global Antimony Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Antimony Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Antimony Market: Regional Analysis
8.1. North America
8.1.1. North America Antimony Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Antimony Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Antimony Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Antimony Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Antimony Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Antimony Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Antimony Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Antimony Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Antimony Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Antimony Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Nrotron Biotechnology Co Ltd
9.1.1. Financials
9.1.2. Product portfolio
9.1.3. Antimony Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.4. Antimony Sales Market Share (%), 2014 - 2018
9.1.5. Business strategy
9.1.6. Recent developments
9.2. Nrotron Biotechnology Co Ltd
9.3. Abbott Laboratories
9.4. BIOTRONIK SE &Co. KG
9.5. William Demart Holding A/S
9.6. LivaNova PLC
9.7. Sonova Holding AG
9.8. Cochlear Limited
9.9. Boston Scientific Corporation
9.10. MED-EL and Medtronic plc. 
9.11. Others.
10. Chapter – Market Research and Findings